C. Patrick Reynolds
Developmental Therapeutics Program
Institute for Pediatric Clinical Research
Department of Pediatrics
Keck School of Medicine
USA
Name/email consistency: high
- Assessing combinations of cytotoxic agents using leukemia cell lines. Reynolds, C.P., Kang, M.H., Keshelava, N., Maurer, B.J. Curr. Drug. Targets (2007)
- Ceramide synthesis and metabolism as a target for cancer therapy. Reynolds, C.P., Maurer, B.J., Kolesnick, R.N. Cancer Lett. (2004)
- Detection and treatment of minimal residual disease in high-risk neuroblastoma. Reynolds, C.P. Pediatr. Transplant (2004)
- Retinoid therapy of high-risk neuroblastoma. Reynolds, C.P., Matthay, K.K., Villablanca, J.G., Maurer, B.J. Cancer Lett. (2003)
- Retinoid therapy of childhood cancer. Reynolds, C.P., Lemons, R.S. Hematol. Oncol. Clin. North Am. (2001)
- Retinoic-acid-resistant neuroblastoma cell lines show altered MYC regulation and high sensitivity to fenretinide. Reynolds, C.P., Wang, Y., Melton, L.J., Einhorn, P.A., Slamon, D.J., Maurer, B.J. Med. Pediatr. Oncol. (2000)
- Differentiating agents in pediatric malignancies: retinoids in neuroblastoma. Reynolds, C.P. Curr. Oncol. Rep (2000)